SLN: Silence Therapeutics Plc Financial Statements

Balance sheet, income statement, and cash flow statements for Silence Therapeutics Plc (SLN).

OverviewDividends

$324.83M Market Cap.

As of 05/11/2025 5:00 PM ET (MRY) • Disclaimer

SLN Market Cap. (MRY)


SLN Shares Outstanding (MRY)


SLN Assets (MRY)


Total Assets

$202.63M

Total Liabilities

$68.61M

Total Investments

$26.00M

SLN Income (MRY)


Revenue

$43.26M

Net Income

-$45.31M

Operating Expense

$94.77M

SLN Cash Flow (MRY)


CF Operations

-$67.64M

CF Investing

-$21.97M

CF Financing

$142.09M

SLN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$202,635,000 (69.64%)

$119,448,000 (-11.11%)

$134,375,000 (11.75%)

$120,242,500 (11.89%)

Assets Current

$187,366,000 (81.64%)

$103,151,000 (-14.65%)

$120,857,500 (11.99%)

$107,916,250 (13.00%)

Assets Non-Current

$15,269,000 (-6.31%)

$16,297,000 (20.56%)

$13,517,500 (9.66%)

$12,326,250 (3.02%)

Goodwill & Intangible Assets

$9,704,000 (-6.18%)

$10,343,000 (-0.66%)

$10,411,250 (9.36%)

$9,520,000 (-6.46%)

Shareholders Equity

-$134,023,000 (-509.39%)

-$21,993,000 (-179.71%)

$27,590,000 (158.88%)

$10,657,500 (-5.88%)

Property Plant & Equipment Net

$1,975,000 (-14.43%)

$2,308,000 (-16.11%)

$2,751,250 (13.22%)

$2,430,000 (72.49%)

Cash & Equivalents

$121,330,000 (76.38%)

$68,789,000 (0.39%)

$68,520,000 (-25.46%)

$91,921,250 (167.90%)

Accumulated Other Comprehensive Income

$11,781,000 (9.85%)

$10,725,000 (311.51%)

$2,606,250 (35.30%)

$1,926,250 (-30.52%)

Deferred Revenue

$52,096,000 (-36.13%)

$81,572,000 (-9.80%)

$90,436,250 (-5.73%)

$95,935,000 (12.24%)

Total Investments

$26,004,000 (0%)

$0 (0%)

$20,765,000 (5418.94%)

$376,250 (-97.08%)

Investments Current

$26,004,000 (0%)

$0 (0%)

$20,410,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$355,000 (-5.65%)

$376,250 (-0.66%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$972,000 (235.17%)

$290,000 (-74.64%)

$1,143,750 (176.44%)

$413,750 (-98.87%)

Trade & Non-Trade Payables

$16,399,000 (5.55%)

$15,537,000 (-1.61%)

$15,791,250 (17.16%)

$13,478,750 (31.63%)

Accumulated Retained Earnings (Deficit)

$474,044,000 (9.76%)

$431,894,000 (231.24%)

-$329,078,750 (-18.07%)

-$278,707,500 (-21.04%)

Tax Assets

$0 (0%)

$0 (0%)

$18,602,500 (114.28%)

$8,681,250 (96.41%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$117,000 (-66.18%)

$346,000 (-37.94%)

$557,500 (225.55%)

$171,250 (-59.82%)

Debt Current

$117,000 (-48.68%)

$228,000 (-59.10%)

$557,500 (225.55%)

$171,250 (-59.82%)

Debt Non-Current

$0 (0%)

$118,000 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$68,612,000 (-29.60%)

$97,455,000 (-8.74%)

$106,785,000 (-2.56%)

$109,585,000 (13.98%)

Liabilities Current

$16,822,000 (-24.69%)

$22,336,000 (-18.57%)

$27,428,750 (44.68%)

$18,958,750 (-40.70%)

Liabilities Non-Current

$51,790,000 (-31.06%)

$75,119,000 (-5.34%)

$79,356,250 (-12.44%)

$90,626,250 (41.23%)

SLN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$43,258,000 (36.71%)

$31,643,000 (46.12%)

$21,655,000 (39.54%)

$15,518,750 (126.59%)

Cost of Revenue

$11,810,000 (-8.21%)

$12,867,000 (-4.43%)

$13,463,000 (44.45%)

$9,320,000 (98.19%)

Selling General & Administrative Expense

$26,884,000 (2.52%)

$26,222,000 (2.10%)

$25,682,000 (2.69%)

$25,010,000 (43.09%)

Research & Development Expense

$67,883,000 (19.22%)

$56,937,000 (30.74%)

$43,550,000 (13.25%)

$38,456,250 (52.23%)

Operating Expenses

$94,767,000 (13.96%)

$83,159,000 (20.12%)

$69,232,000 (9.08%)

$63,466,250 (35.16%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$65,000 (-83.90%)

Income Tax Expense

$845,000 (-11.61%)

$956,000 (38.95%)

$688,000 (108.54%)

-$8,057,500 (-84.49%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$45,309,000 (16.45%)

-$54,228,000 (-7.74%)

-$50,334,000 (-2.18%)

-$49,262,500 (-21.09%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$45,309,000 (16.45%)

-$54,228,000 (-7.74%)

-$50,334,000 (-2.18%)

-$49,262,500 (-21.09%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$45,309,000 (16.45%)

-$54,228,000 (-7.74%)

-$50,334,000 (-2.18%)

-$49,262,500 (-21.09%)

Weighted Average Shares

$138,752,224 (24.69%)

$111,277,250 (15.21%)

$96,584,512 (7.58%)

$89,777,000 (14.55%)

Weighted Average Shares Diluted

$138,752,224 (24.69%)

$111,277,250 (15.21%)

$96,584,512

-

Earning Before Interest & Taxes (EBIT)

-$44,464,000 (16.53%)

-$53,272,000 (-7.30%)

-$49,646,000 (13.29%)

-$57,255,000 (-28.24%)

Gross Profit

$31,448,000 (67.49%)

$18,776,000 (129.20%)

$8,192,000 (32.16%)

$6,198,750 (188.82%)

Operating Income

-$63,319,000 (1.65%)

-$64,383,000 (-5.48%)

-$61,040,000 (-6.59%)

-$57,267,500 (-27.80%)

SLN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$21,966,000 (-213.85%)

$19,294,000 (194.13%)

-$20,498,000 (-289.01%)

$10,845,000 (-9.79%)

Net Cash Flow from Financing

$142,087,000 (344.90%)

$31,937,000 (-39.26%)

$52,581,000 (36.97%)

$38,388,750 (99.06%)

Net Cash Flow from Operations

-$67,640,000 (-36.75%)

-$49,462,000 (13.29%)

-$57,044,000 (-770.51%)

$8,507,500 (163.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

$52,481,000 (2866.70%)

$1,769,000 (107.09%)

-$24,961,000 (-143.23%)

$57,741,250 (223.71%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$21,755,000 (-212.43%)

$19,350,000 (196.98%)

-$19,953,000 (-259.62%)

$12,500,000 (0.00%)

Capital Expenditure

-$211,000 (-276.79%)

-$56,000 (67.63%)

-$173,000 (89.44%)

-$1,638,750 (-158.07%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$263,750 (47.51%)

Issuance (Purchase) of Equity Shares

$142,087,000 (344.90%)

$31,937,000 (-39.26%)

$52,581,000 (36.04%)

$38,652,500 (95.34%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$60,000 (-91.99%)

$749,000 (109.23%)

-$8,119,000 (-6085.90%)

-$131,250 (68.75%)

Share Based Compensation

$16,307,000 (0.20%)

$16,274,000 (28.28%)

$12,686,000 (17.57%)

$10,790,000 (96.41%)

Depreciation Amortization & Accretion

$593,000 (-4.51%)

$621,000 (4.19%)

$596,000 (16.01%)

$513,750 (-13.66%)

SLN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

72.70% (22.60%)

59.30% (56.88%)

37.80% (-5.26%)

39.90% (27.48%)

Profit Margin

-104.70% (38.91%)

-171.40% (26.25%)

-232.40% (26.78%)

-317.40% (46.57%)

EBITDA Margin

-101.40% (39.06%)

-166.40% (26.53%)

-226.50% (38.05%)

-365.60% (43.16%)

Return on Average Equity (ROAE)

-64.80% (88.33%)

-555.30% (-91.15%)

-290.50% (35.19%)

-448.20% (-106.35%)

Return on Average Assets (ROAA)

-20.30% (55.48%)

-45.60% (-13.72%)

-40.10% (7.39%)

-43.30% (12.17%)

Return on Sales (ROS)

-102.80% (38.95%)

-168.40% (26.56%)

-229.30% (37.84%)

-368.90% (43.41%)

Return on Invested Capital (ROIC)

-59.40% (70.15%)

-199.00% (59.70%)

-493.80% (-35.62%)

-364.10% (-106.99%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-6.95 (41.19%)

-11.82 (-20.87%)

-9.78

-

Price to Sales Ratio (P/S)

7.36 (-63.87%)

20.36 (-10.19%)

22.67 (-50.79%)

46.07 (-45.10%)

Price to Book Ratio (P/B)

-2.42 (92.06%)

-30.54 (-253.94%)

19.84 (-70.43%)

67.08 (32.17%)

Debt to Equity Ratio (D/E)

-0.51 (88.45%)

-4.43 (-214.50%)

3.87 (-62.36%)

10.28 (21.11%)

Earnings Per Share (EPS)

-0.99 (32.65%)

-1.47 (5.77%)

-1.56

-

Sales Per Share (SPS)

0.94 (9.61%)

0.85 (26.75%)

0.67 (29.67%)

0.52 (98.09%)

Free Cash Flow Per Share (FCFPS)

-1.47 (-9.89%)

-1.33 (24.87%)

-1.78 (-872.61%)

0.23 (142.59%)

Book Value Per Share (BVPS)

-2.9 (-388.70%)

-0.59 (-169.19%)

0.86 (140.73%)

0.36 (-17.78%)

Tangible Assets Book Value Per Share (TABVPS)

4.17 (41.82%)

2.94 (-23.61%)

3.85 (4.05%)

3.7 (-0.64%)

Enterprise Value Over EBIT (EV/EBIT)

-6 (45.45%)

-11 (-22.22%)

-9 (18.18%)

-11 (15.38%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.64 (50.37%)

-11.37 (-28.06%)

-8.88 (19.50%)

-11.03 (13.53%)

Asset Turnover

0.19 (-27.07%)

0.27 (54.65%)

0.17 (26.47%)

0.14 (63.86%)

Current Ratio

11.14 (141.19%)

4.62 (4.81%)

4.41 (-22.59%)

5.69 (90.56%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$67,851,000 (-37.02%)

-$49,518,000 (13.46%)

-$57,217,000 (-933.00%)

$6,868,750 (148.70%)

Enterprise Value (EV)

$247,567,277 (-58.64%)

$598,568,706 (37.45%)

$435,470,421 (-30.41%)

$625,744,527 (11.38%)

Earnings Before Tax (EBT)

-$44,464,000 (16.53%)

-$53,272,000 (-7.30%)

-$49,646,000 (13.39%)

-$57,320,000 (-27.23%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$43,871,000 (16.68%)

-$52,651,000 (-7.34%)

-$49,050,000 (13.55%)

-$56,741,250 (-28.80%)

Invested Capital

$54,896,000 (199.55%)

$18,326,000 (-35.86%)

$28,572,500 (207700.00%)

$13,750 (-99.96%)

Working Capital

$170,544,000 (111.03%)

$80,815,000 (-13.50%)

$93,428,750 (5.03%)

$88,957,500 (40.02%)

Tangible Asset Value

$192,931,000 (76.83%)

$109,105,000 (-11.99%)

$123,963,750 (11.96%)

$110,722,500 (13.81%)

Market Capitalization

$324,834,777 (-51.64%)

$671,689,956 (22.71%)

$547,367,921 (-23.44%)

$714,917,027 (24.40%)

Average Equity

$69,908,000 (615.87%)

$9,765,500 (-43.65%)

$17,329,062 (57.67%)

$10,990,625 (-41.32%)

Average Assets

$223,283,125 (87.76%)

$118,921,375 (-5.27%)

$125,539,062 (10.26%)

$113,853,125 (37.95%)

Invested Capital Average

$74,894,312 (179.81%)

$26,766,188 (166.21%)

$10,054,375 (-36.05%)

$15,723,125 (-38.06%)

Shares

141,644,488 (22.10%)

116,009,788 (7.74%)

107,680,012 (19.94%)

89,777,000 (14.55%)